Novel epitope evoking CD138 antigen‐specific cytotoxic T lymphocytes targeting multiple myeloma and other plasma cell disorders
Author:
Affiliation:
1. Dana‐Farber Cancer Institute
2. Harvard Medical School
3. VA Boston Healthcare System, Boston, MA, USA
Publisher
Wiley
Subject
Hematology
Link
https://onlinelibrary.wiley.com/doi/pdf/10.1111/j.1365-2141.2011.08850.x
Reference59 articles.
1. Identification of novel CD33 antigen-specific peptides for the generation of cytotoxic T lymphocytes against acute myeloid leukemia
2. Identification of CD19 and CD20 Peptides for Induction of Antigen-Specific CTLs against B-Cell Malignancies
3. Identification of novel myeloma-specific XBP1 peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma
4. XBP1s levels are implicated in the biology and outcome of myeloma mediating different clinical outcomes to thalidomide-based treatments
5. Chimeric NKG2D receptor–expressing T cells as an immunotherapy for multiple myeloma
Cited by 30 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. An Anti-CD138-Targeted Interferon-Alpha Has Broad Efficacy in Solid Tumors Through Direct Tumor Cell Killing and Intratumoral Immune Modulation;Journal of Interferon & Cytokine Research;2024-09-01
2. LAG‐3 : recent developments in combinational therapies in cancer;Cancer Science;2024-05-04
3. Targeted therapy for multiple myeloma: an overview on CD138-based strategies;Frontiers in Oncology;2024-04-09
4. DOCK2 contributes to pulmonary fibrosis by promoting lung fibroblast to myofibroblast transition;American Journal of Physiology-Cell Physiology;2022-07-01
5. Targeting syndecan-1: new opportunities in cancer therapy;American Journal of Physiology-Cell Physiology;2022-07-01
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3